Chimeric Therapeutics Ltd
ASX:CHM
Chimeric Therapeutics Ltd
ASX:CHM
Price:
0.165
AUD
-17.5%
Market Closed
Market Cap:
AU$8.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Chimeric Therapeutics Ltd
ASX:CHM
|
AU |
|
Industrial & Infrastructure Fund Investment Corp
TSE:3249
|
JP |
|
Coca-Cola Femsa SAB de CV
NYSE:KOF
|
MX |
|
Irani Papel e Embalagem SA
BOVESPA:RANI3
|
BR |
|
Medley Inc
TSE:4480
|
JP |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
CN |
|
Talkweb Information System Co Ltd
SZSE:002261
|
CN |
Income Statement
Earnings Waterfall
Chimeric Therapeutics Ltd
Chimeric Therapeutics Ltd
Income Statement
Chimeric Therapeutics Ltd
Chimeric Therapeutics Ltd
Currency: AUD
| Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
4
N/A
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
0
N/A
|
|
| Operating Income | |||||||||
| Operating Expenses |
(15)
|
(17)
|
(26)
|
(11)
|
(11)
|
(18)
|
(13)
|
(13)
|
|
| Selling, General & Administrative |
(11)
|
(13)
|
(15)
|
(12)
|
(9)
|
(9)
|
(7)
|
(7)
|
|
| R&D |
(5)
|
(9)
|
(13)
|
(12)
|
(10)
|
(11)
|
(13)
|
(11)
|
|
| Depreciation & Amortization |
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
|
| Other Operating Expenses |
2
|
5
|
4
|
13
|
9
|
2
|
9
|
6
|
|
| Operating Income |
(15)
N/A
|
(17)
-14%
|
(26)
-49%
|
(11)
+58%
|
(11)
-5%
|
(18)
-56%
|
(10)
+43%
|
(9)
+12%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
0
|
(0)
|
(0)
|
|
| Non-Recurring Items |
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(10)
|
|
| Pre-Tax Income |
(16)
N/A
|
(18)
-12%
|
(26)
-46%
|
(12)
+54%
|
(13)
-6%
|
(18)
-41%
|
(10)
+41%
|
(19)
-82%
|
|
| Net Income | |||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(16)
|
(18)
|
(26)
|
(12)
|
(13)
|
(18)
|
(10)
|
(19)
|
|
| Net Income |
(16)
N/A
|
(18)
-13%
|
(26)
-44%
|
(12)
+55%
|
(13)
-7%
|
(18)
-42%
|
(10)
+42%
|
(19)
-80%
|
|
| EPS (Diluted) |
-0.04
N/A
|
-0.04
N/A
|
-0.06
-50%
|
-0.03
+50%
|
-0.02
+33%
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
|
Switch to:
Switch to:
See Also
Other Chimeric Therapeutics Ltd listings:
Discover More
